Sadanyl en es it fr

Sadanyl Brand names, Sadanyl Analogs

Sadanyl Brand Names Mixture

  • No information avaliable

Sadanyl Chemical_Formula


Sadanyl RX_link

No information avaliable

Sadanyl fda sheet

Sadanyl msds (material safety sheet)

Sadanyl Synthesis Reference

No information avaliable

Sadanyl Molecular Weight

309.469 g/mol

Sadanyl Melting Point

< 25 oC

Sadanyl H2O Solubility

Soluble as HCl salt

Sadanyl State


Sadanyl LogP


Sadanyl Dosage Forms

Tablets (oral, 1 mg)

Sadanyl Indication

Used for the symptomatic treatment of parkinsonism.

Sadanyl Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Sadanyl Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Sadanyl side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Sadanyl Patient Information

Sadanyl Organisms Affected

Humans and other mammals